HIGHER RISK OF MINOR BLEEDING IN WOMEN THAN IN MEN WITH ATRIAL FIBRILLATION TREATED WITH DABIGATRAN

Vene N.; Mavri A.; Sinigoj P.; Kosmelj K.; Vizintin-Cuderman T.; Tratar G.; Gubensek M.; Miklic M.; Ostasevski-Fernandez N.

首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >HIGHER RISK OF MINOR BLEEDING IN WOMEN THAN IN MEN WITH ATRIAL FIBRILLATION TREATED WITH DABIGATRAN

【24h】

HIGHER RISK OF MINOR BLEEDING IN WOMEN THAN IN MEN WITH ATRIAL FIBRILLATION TREATED WITH DABIGATRAN

机译：与达比加群治疗的男性房颤相比，男性轻微出血的风险更高

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis 》 |2014年第3期| 共1页
作者
Vene N.; Mavri A.; Sinigoj P.; Kosmelj K.; Vizintin-Cuderman T.; Tratar G.; Gubensek M.; Miklic M.; Ostasevski-Fernandez N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学 ;
关键词

相似文献

外文文献
中文文献
专利

1. HIGHER RISK OF MINOR BLEEDING IN WOMEN THAN IN MEN WITH ATRIAL FIBRILLATION TREATED WITH DABIGATRAN [J] . Vene N., Mavri A., Sinigoj P., Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2014 ,第Suppla3期

机译：与达比加群治疗的男性房颤相比，男性轻微出血的风险更高
2. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation [J] . Graham David J., Reichman Marsha E., Wernecke Michael, JAMA internal medicine . 2016 ,第11期

机译：达比加群或利伐沙班治疗非瓣膜性心房颤动的老年医疗保险受益人的中风，出血和死亡率风险
3. Letter by Lavine Regarding Article, "Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation" [J] . Lavine Jay B. Circulation: An Official Journal of the American Heart Association . 2015 ,第14期

机译：Lavine关于文章“用达比加群或华法林治疗的非瓣膜性心房颤动的老年医疗保险患者的心血管，出血和死亡风险”的信函
4. Modelling Left Atrial Flow and Blood Coagulation for Risk of Thrombus Formation in Atrial Fibrillation [C] . Ahmed Qureshi, Omar Darwish, Des Dillon-Murphy, Computing in Cardiology . 2020

机译：对心房颤动血栓形成风险造型左心动流动和血液凝固
5. Precision Medicine in Atrial Fibrillation: A Risk Model for Management with Dabigatran v. Warfarin [D] . Ader, Jeremy. 2018

机译：心房颤动的精密药：Dabigatran v管理的风险模型。华法林
6. Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists [O] . Géric Maura, Pierre-Olivier Blotière, Kim Bouillon, -1

机译：达比加群或利伐沙班与维生素K拮抗剂新治疗的非瓣膜性心房颤动患者近期出血和动脉血栓栓塞事件风险的比较
7. An Exploratory Association Analysis of ABCB1 rs1045642 and ABCB1 rs4148738 with Non-Major Bleeding Risk in Atrial Fibrillation Patients Treated with Dabigatran or Apixaban [O] . Adela-Nicoleta Roşian, Mihaela Iancu, Adrian Pavel Trifa, 2020

机译：ABCB1 rs1045642和ABCB1卢比141738对达比格特兰或阿列西克兰治疗的心房颤动患者非重大出血风险的探索性关联分析

HIGHER RISK OF MINOR BLEEDING IN WOMEN THAN IN MEN WITH ATRIAL FIBRILLATION TREATED WITH DABIGATRAN

著录项

相似文献

相关主题

期刊订阅